📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

CD34+CD19-CD22+ B-cell progenitors may underlie phenotypic escape in patients treated with CD19-directed therapies. (2022)

First Author: Bueno C

Attributed to: The Oxford Single Cell Biology Consortium funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1182/blood.2021014840

PubMed Identifier: 35421218

Publication URI: http://europepmc.org/abstract/MED/35421218

Type: Journal Article/Review

Volume: 140

Parent Publication: Blood

Issue: 1

ISSN: 0006-4971